Asprin and Caffeine

CHEBI:CHEBI_752092

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
ASPIRIN
rxcui
211292
pharm_class
Decreased Platelet Aggregation [PE]
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Xanthines [CS]
unii
R16CO5Y76E
pharm_class_pe
Decreased Platelet Aggregation [PE]
product_type
HUMAN OTC DRUG
active_ingredient_strength
32 mg/1
marketing_category
OTC MONOGRAPH DRUG
application_number
M013
labeler_name
Insight Pharmaceuticals LLC
manufacturer_name
Insight Pharmaceuticals LLC
generic_name
Asprin and Caffeine
brand_name
Anacin
brand_name_base
Anacin
product_ndc
63736-200
marketing_start_date
20090625
package_marketing_start_date
20090625
spl_id
62c078ed-ff8e-4aba-8f33-1792e894ecaa
package_ndc
63736-200-93
package_description
1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE
spl_set_id
51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class